Gene · 8694
Papers2,292
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,292
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DGAT2 Inhibition Potentiates Lipid Droplet Formation To Reduce Cytotoxicity in APOL1 Kidney Risk Variants. | J Am Soc Nephrol | 2022 | 35232775 | PubTator, text mining | PubMed |
| Mucor circinelloides: a model organism for oleaginous fungi and its potential applications in bioactive lipid production. | Microb Cell Fact | 2022 | 35227264 | PubTator, text mining | PubMed |
| The Roles of EphB2 in Cancer. | Front Cell Dev Biol | 2022 | 35223830 | PubTator, text mining | PubMed |
| Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer. | Nutrients | 2022 | 35215499 | PubTator, text mining | PubMed |
| Artificial Lipid Droplets: Novel Effective Biomaterials to Protect Cells against Oxidative Stress and Lipotoxicity. | Nanomaterials (Basel) | 2022 | 35215001 | PubTator, text mining | PubMed |
| Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates. | Biomedicines | 2022 | 35203484 | PubTator, text mining | PubMed |
Selective PPARα Modulator Pemafibrate and Sodium-Glucose Cotransporter 2 Inhibitor Tofogliflozin Combination Treatment Improved Histopathology in Experimental Mice Model of Non-Alcoholic Steatohepatitis. | Cells | 2022 | 35203369 | PubTator, text mining | PubMed |
| Design and synthesis of novel spirocyclic carboxylic acids as potent and orally bioavailable DGAT1 inhibitors and their biological evaluation. | Bioorg Med Chem Lett | 2022 | 35189320 | PubTator, text mining | PubMed |
| The Obesity-Related Metabolic Gene HSD17B8 Protects Against Breast Cancer: High RNA/Protein Expression Means a Better Prognosis. | Med Sci Monit | 2022 | 35184130 | PubTator, text mining | PubMed |
| Study on the effect of different types of sugar on lipid deposition in goose fatty liver. | Poult Sci | 2022 | 35172237 | PubTator, text mining | PubMed |
| Genes and Longevity of Lifespan. | Int J Mol Sci | 2022 | 35163422 | PubTator, text mining | PubMed |
| The Role of Sphingolipid Signaling in Oxidative Lung Injury and Pathogenesis of Bronchopulmonary Dysplasia. | Int J Mol Sci | 2022 | 35163176 | PubTator, text mining | PubMed |
| Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson's Disease. | Int J Mol Sci | 2022 | 35163013 | PubTator, text mining | PubMed |
| Quercetin Reduces Lipid Accumulation in a Cell Model of NAFLD by Inhibiting De Novo Fatty Acid Synthesis through the Acetyl-CoA Carboxylase 1/AMPK/PP2A Axis. | Int J Mol Sci | 2022 | 35162967 | PubTator, text mining | PubMed |
| Supplementation of Enriched Polyunsaturated Fatty Acids and CLA Cheese on High Fat Diet: Effects on Lipid Metabolism and Fat Profile. | Foods | 2022 | 35159548 | PubTator, text mining | PubMed |
| Punicic Acid and Its Role in the Prevention of Neurological Disorders: A Review. | Foods | 2022 | 35159404 | PubTator, text mining | PubMed |
| Dissecting the Mechanism of Action of Spiperone-A Candidate for Drug Repurposing for Colorectal Cancer. | Cancers (Basel) | 2022 | 35159043 | PubTator, text mining | PubMed |
| Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections. | Front Immunol | 2022 | 35154105 | PubTator, text mining | PubMed |
| Overexpression of Two New Acyl-CoA:Diacylglycerol Acyltransferase 2-Like Acyl-CoA:Sterol Acyltransferases Enhanced Squalene Accumulation in Aurantiochytrium limacinum. | Front Microbiol | 2022 | 35145505 | PubTator, text mining | PubMed |
| Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia. | Lipids Health Dis | 2022 | 35144640 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8694/papers?page=34